Last reviewed · How we verify

NCT03959696: PRIMED

Promoting Informed Decisions About Cancer Screening in Older Adults

Completed NA Results posted Last updated 6 January 2025
What this trial tests

NA trial testing Notification in Colorectal Cancer Screening in 536 participants. Completed in 30 August 2022.

Timeline
1 May 2019
Primary endpoint
30 April 2022
30 August 2022

Quick facts

Lead sponsorMassachusetts General Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposehealth services research
Enrollment536
Start date1 May 2019
Primary completion30 April 2022
Estimated completion30 August 2022
Sites5 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Massachusetts General Hospital

Who can join

21 and older, any sex, with Colorectal Cancer Screening. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Shared Decision Making Process (SDMP) Scale Score Primary · About 1 week after the physician visit

The SDMP scale is a short, patient-reported scale that asks patients about discussion of options, pros and cons of colonoscopy and discussion of patients' preferences. Total scores range from 0-4, with higher scores indicating more shared decision making.

GroupValue95% CI
Notification Only Arm/ Patients1.1± 1.2
Training and Notification Arm/ Patients1.5± 1.2
Patients' Colorectal Cancer Screening Knowledge Score Secondary · 1 week after physician visit

Colorectal Cancer (CRC) Screening Knowledge will be assessed with multiple choice knowledge items adapted from the CRC Decision Quality Instrument. A total score from 0-100% will be calculated based on the number of correct answers, with higher scores indicating higher knowledge.

GroupValue95% CI
Notification Only Arm/ Patients61± 18.8
Training and Notification Arm/ Patients63± 17.7
Percentage of Patients Who Received Preferred Approach to Colorectal Cancer Testing Secondary · 1 week after physician visit (preference); 12 months after physician visit (testing)

Colorectal Cancer Screening Preference assessed with 1 item adapted from the CRC Decision Quality Instrument will be compared with the screening approach followed (assessed via chart review and patient report) to determine the percentage of patients who received preferred approach to testing.

GroupValue95% CI
Notification Only Arm/ Patients103
Training and Notification Arm/ Patients115
Physician's Shared Decision Making Skills Secondary · Baseline

The transcripts from the simulated patient interactions will be scored by two coders using Braddock's Informed Decision Making framework. Total scores range from 0-9 with higher scores indicating more shared decision making elements in the interaction.

GroupValue95% CI
Notification Only Arm/Providers5.5± 1.3
Training and Notification Arm/ Providers6.1± 1.6
Colorectal Cancer Screening Rates Secondary · 1 year

The chart review results of cancer screening rates for patients enrolled in the study.

GroupValue95% CI
Notification Only Arm/Patients29.123.3 – 35.5
Training and Notification Arm/Patients38.632.3 – 45.1
Clinician Satisfaction With the Visit Secondary · 1 week post visit

The percentage of study patient visits where the clinicians' reported that they were 'extremely or very satisfied' will be compared across arms.

GroupValue95% CI
Notification Only Arm/Patient138
Training and Notification Arm/Patient171
Companion SDM Process Scale Score Secondary · About a week after physician visit

Companions will complete an adapted version of the SDM Process survey to provide a different perspective on the conversation and involvement of the patient. A total score will range from 0-4, with higher scores indicating more shared decision making.

GroupValue95% CI
Notification Only Arm/Companion2.1± 1.3
Training and Notification Arm/Companion1.9± 1.2
Clinician Attitude Toward Shared Decision Making Secondary · Baseline

The investigators will use five items to assess clinicians' confidence in Shared Decision Making Skills and Barriers to SDM. A total confidence score (0-20) with higher scores indicating higher confidence and a barrier score (0-8) higher scores indicating more barriers will be calculated.

Total Confidence
GroupValue95% CI
Notification Only Arm/Providers10.2± 2.4
Training and Notification Arm/ Providers10.7± 1.8
Barrier Confidence
GroupValue95% CI
Notification Only Arm/Providers0.79± 1.4
Training and Notification Arm/ Providers0.88± 1.57

Sponsor's own description

This project aims to examine the impact of different interventions designed to help individualize colorectal cancer (CRC) screening decisions in adults aged 76-85. Clinicians will be assigned by chance to one of two arms. In the Intervention arm, clinician participants will complete a training course and will also be notified of patients in the target age group who are due for a discussion about CRC screening. In the Comparator arm, clinician participants will be notified of their patients in the target age group with an upcoming visit who are due for a discussion about CRC screening. The investigators expect that patients seen by clinicians in the intervention arm will report more involvement in the decision making process, be more knowledgeable about the risks and benefits of CRC screening, and will have better quality decisions. Further, the investigators expect that the physicians in the intervention arm will have greater confidence in and demonstrate more skills for conducting shared decision making conversations as compared to those in the control arm.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Promoting Informed Decisions About Colorectal Cancer Screening in Older Adults (PRIMED Study): a Physician Cluster Randomized Trial.
    Sepucha K, Han PKJ, Chang Y, Atlas SJ, et al · · 2023 · cited 9× · PMID 35931908 · DOI 10.1007/s11606-022-07738-4
  2. Shared Decision-Making in Colorectal Cancer Screening for Older Adults: A Secondary Analysis of a Cluster Randomized Clinical Trial.
    Sepucha KR, Chang Y, Valentine KD, Atlas SJ, et al · · 2024 · cited 3× · PMID 39178001 · DOI 10.1001/jamanetworkopen.2024.29645
  3. Talking, not training, increased the accuracy of physicians' diagnosis of their patients' preferences for colon cancer screening.
    Valentine K, Leavitt L, Simmons L, Sepucha K, et al · · 2024 · cited 2× · PMID 37976668 · DOI 10.1016/j.pec.2023.108047
  4. Exploring the Lack of Concordance between the Preferred and Actual Approach to Colorectal Cancer Screening in Older Adults: A Qualitative Study.
    Kraun L, Leavitt L, Valentine KD, Atlas SJ, et al · · 2026 · PMID 42015676 · DOI 10.1177/0272989x261441643

Verify or expand the search:

Other trials of Notification

Trials testing the same drug.

Other recruiting trials for Colorectal Cancer Screening

Currently open trials in the same condition.

Other Massachusetts General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03959696.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing